US: New Jersey Proposes Introducing Menthol Ban Before The FDA’s

Industry Insight
Jul.26.2022
Despite a national menthol ban announced by the Food and Drug Administration’ (FDA) last April, New Jersey lawmakers propose a sooner statewide ban.

A study published in BMJ’s Tobacco Control earlier this year, concluded that a menthol ban would avoid 16,250 tobacco-related deaths per year by 2060. “This work is the culmination of a series of sequential projects aimed to assess the impact that a menthol ban could have on smoking, tobacco use and downstream health effects,” said study author Rafael Meza, a professor of epidemiology at U-M’s School of Public Health. “Our findings show that a menthol ban could result in considerable health gains and highlight the urgency for final approval and implementation of the ban.”

US: New Jersey Proposes Introducing Menthol Ban Before The FDA’s

The findings were based on the data analysis and computational modeling infrastructure compiled as part of the Center for the Assessment of Tobacco Regulations. The research team used the Smoking and Vaping Model, a simulation model they had previously developed to study smoking and vaping behaviour with regards to menthol and non-menthol cigarettes.

 

They found that in the presence of a menthol ban, combined menthol and non-menthol cigarette smoking would decline by 15% until 2026. Deaths attributable to smoking and vaping were estimated to drop by about 5% and life-years lost by 8.8%. This would translate to 16,250 less deaths per year and 11 million life-years gained (almost 300,000 per year) over a 40-year period. To this effect last April, the FDA announced the long discussed ban on menthols, launching a consultation process which closed earlier this month on July 5th, 2022.

 

However, New Jersey’s Assembly Health Committee seems keen on taking matters in their own hands and have just voted in favour of the statewide ban on the sale of menthol products, under which violators would face fines of up to $1,000. The proposed rule still has to clear the state Assembly and Senate before heading to the governor’s desk to be signed off.

 

Cannabis legalization

 

In other news, In 2021 New Jersey’s Democratic Gov. Phil Murphy signed a package of “historic adult-use cannabis reform bills,” legalizing marijuana across the State. “Our current marijuana prohibition laws have failed every test of social justice, which is why for years I’ve strongly supported the legalization of adult-use cannabis,” said Murphy in a statement at the time.

 

“Maintaining a status quo that allows tens of thousands, disproportionately people of color, to be arrested in New Jersey each year for low-level drug offenses is unjust and indefensible.”

 

“This November, New Jerseyans voted overwhelmingly in support of creating a well-regulated adult-use cannabis market. Although this process has taken longer than anticipated, I believe it is ending in the right place and will ultimately serve as a national model,” he said.

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

Special Report| War continues to shape the Ukrainian tobacco market
Special Report| War continues to shape the Ukrainian tobacco market
Four years into the war, Ukraine’s tobacco market is being reshaped by stress-driven consumption, tax pressure, youth e-cigarette use and a growing illicit segment. Surveys point to rising tobacco and nicotine product use, while higher excise duties and shadow trade are adding new complexity to the market.
Apr.17
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
KT&G disclosed in a regulatory filing on Friday that Capital Research and Management Company, the investment management arm of Capital Group, had acquired a 5.61% stake through purchases made on April 22 and May 4. The move places Capital Group among KT&G’s prominent foreign shareholders, alongside BlackRock, First Eagle Investment Management and Singapore’s sovereign wealth fund GIC.
May.08 by 2FIRSTS.ai
Al Fakher Enters the Oral Nicotine Market With Four Flavors
Al Fakher Enters the Oral Nicotine Market With Four Flavors
Al Fakher has launched nicotine pouches, marking the world’s leading hookah brand’s entry into the modern oral nicotine category.
Apr.01 by 2FIRSTS.ai